Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
1 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Impacts of Posttransplant Cyclophosphamide Dose on Graft-versus-leukemia Effects
via HLA-B Leader in HLA-haploidentical Peripheral Blood Stem Cell
Transplantation.
Acta Haematol. 2024 Mar 1. doi: 10.1159/000538078.
PubMed
Abstract available
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification
and management.
Am J Hematol. 2024 Mar 7. doi: 10.1002/ajh.27271.
PubMed
Abstract available
Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and
treatment-Annual updates in hematological malignancies.
Am J Hematol. 2024 Mar 5. doi: 10.1002/ajh.27240.
PubMed
Abstract available
Mutations of epigenetic modifier genes predict poor outcome in adult acute
lymphoblastic leukemia.
Ann Hematol. 2024 Mar 7. doi: 10.1007/s00277-024-05681.
PubMed
Abstract available
Acute myeloid leukemia with rare recurring translocations-an overview of the
entities included in the international consensus classification.
Ann Hematol. 2024 Mar 6. doi: 10.1007/s00277-024-05680.
PubMed
Abstract available
Final results on effectiveness and safety of Ibrutinib in patients with chronic
lymphocytic leukemia from the non-interventional FIRE study.
Ann Hematol. 2024 Mar 6. doi: 10.1007/s00277-024-05666.
PubMed
Abstract available
Noncoding mutations drive persistence of a founder preleukemic clone which
initiates late relapse in T-ALL.
Blood. 2024;143:933-937.
PubMed
Abstract available
Binucleated and cloverleaf-shaped nucleus in lymphocytes in CLL.
Blood. 2024;143:833.
PubMed
CD155/PVR determines Acute Myeloid Leukemia targeting by Delta One T cells.
Blood. 2024 Feb 16:blood.2023022992. doi: 10.1182/blood.2023022992.
PubMed
Abstract available
Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-Cell
Acute Lymphoblastic Leukemia.
Blood. 2024 Mar 4:blood.2023022455. doi: 10.1182/blood.2023022455.
PubMed
Abstract available
Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic
Leukemia in Children.
Blood. 2024 Mar 6:blood.2023023336. doi: 10.1182/blood.2023023336.
PubMed
Abstract available
Occult ALK-negative anaplastic large cell lymphoma complicating chronic
lymphocytic leukemia.
Blood. 2024;143:938.
PubMed
Colom Diaz PA, Mistry JJ, Trowbridge JJ. Hematopoietic stem cell aging and
leukemia transformation. Blood. 2023;142(6):533-542.
Blood. 2024;143:939.
PubMed
Nilotinib with or without cytarabine for Philadelphia positive acute
lymphoblastic leukemia.
Blood. 2024 Mar 7:blood.2023023502. doi: 10.1182/blood.2023023502.
PubMed
Abstract available
Epigenetic control over cell-intrinsic immune response antagonizes self-renewal
in acute myeloid leukemia.
Blood. 2024 Mar 8:blood.2023021640. doi: 10.1182/blood.2023021640.
PubMed
Abstract available
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute
myeloid leukemia patients who received first allogeneic hematopoietic stem cell
transplantation in measurable residual disease-negative CR1.
Bone Marrow Transplant. 2024 Mar 4. doi: 10.1038/s41409-024-02255.
PubMed
Abstract available
Minimum latency effects for cancer associated with exposures to radiation or
other carcinogens.
Br J Cancer. 2024;130:819-829.
PubMed
Abstract available
Predictive performance of population pharmacokinetic models of imatinib in
chronic myeloid leukemia patients.
Cancer Chemother Pharmacol. 2024 Mar 5. doi: 10.1007/s00280-024-04644.
PubMed
Abstract available
Successful use of Palbociclib combined with Venetoclax and Azacitidine in an
adult with refractory/relapsed therapy-related acute myeloid leukemia.
Cancer Chemother Pharmacol. 2024 Mar 2. doi: 10.1007/s00280-024-04642.
PubMed
Abstract available
Histiocytic sarcoma following CAR T-cell therapy: a case report.
Int J Hematol. 2024;119:338-341.
PubMed
Abstract available
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute
myeloid leukemia.
Int J Hematol. 2024 Mar 5. doi: 10.1007/s12185-024-03729.
PubMed
Abstract available
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult
Philadelphia-Positive ALL.
J Clin Oncol. 2024;42:881-885.
PubMed
Abstract available
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the
AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in
High-Risk ALL: Results of a Randomized Study.
J Clin Oncol. 2024;42:915-926.
PubMed
Abstract available
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.
J Clin Oncol. 2024;42:907-914.
PubMed
Abstract available
Bartonella henselae Infection and Lymphadenopathy in a Patient With T Cell Acute
Lymphoblastic Leukemia.
J Pediatr Hematol Oncol. 2024 Feb 29. doi: 10.1097/MPH.0000000000002844.
PubMed
Abstract available
Acute Myeloid Leukemia and Next-Generation Sequencing Panels for Diagnosis: A
Comprehensive Review.
J Pediatr Hematol Oncol. 2024 Feb 29. doi: 10.1097/MPH.0000000000002840.
PubMed
Abstract available
KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia.
Leuk Res. 2024;138:107466.
PubMed
Clinical outcomes of patients with acute myeloid leukemia and cardiovascular
disease.
Leuk Res. 2024;138:107456.
PubMed
Abstract available
Proteomic analysis of adult T-cell leukemia/lymphoma: A biomarker identification
strategy based on preparation and in-solution digestion methods of total
proteins.
Leuk Res. 2024;138:107454.
PubMed
Abstract available
Inherent genome instability underlies trisomy 21-associated myeloid malignancies.
Leukemia. 2024;38:521-529.
PubMed
Abstract available
Harnessing upregulated E-selectin while enhancing SDF-1alpha sensing redirects
infused NK cells to the AML-perturbed bone marrow.
Leukemia. 2024;38:579-589.
PubMed
Abstract available
Loss of thymocyte competition underlies the tumor suppressive functions of the
E2a transcription factor in T-ALL.
Leukemia. 2024;38:491-501.
PubMed
Abstract available
DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced
apoptosis in monosomy 5/del(5q) AML.
Leukemia. 2024;38:530-537.
PubMed
Abstract available
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions
and EVI1 overexpression.
Leukemia. 2024;38:545-556.
PubMed
Abstract available
Genomic and global gene expression profiling in pediatric and young adult acute
leukemia with PICALM::MLLT10 Fusion.
Leukemia. 2024 Mar 1. doi: 10.1038/s41375-024-02194.
PubMed
Abstract available
Asparaginase completion among adults including older patients with acute
lymphoblastic leukemia treated with a modified DFCI protocol.
Leukemia. 2024 Mar 2. doi: 10.1038/s41375-024-02201.
PubMed
Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute
myeloid leukemia.
Leukemia. 2024 Mar 7. doi: 10.1038/s41375-024-02193.
PubMed
Abstract available
Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to
distort a multilineage differentiation program.
Proc Natl Acad Sci U S A. 2024;121:e2317147121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.